Advanced SearchSearch Tips
Caffeine and Carbamazepine: Detection in Nakdong River Basin and Behavior under Drinking Water Treatment Processes
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
Caffeine and Carbamazepine: Detection in Nakdong River Basin and Behavior under Drinking Water Treatment Processes
Son, Hee-Jong; Yeom, Hoon-Sik; Jung, Jong-Moon; Jang, Seong-Ho; Kim, Han-Soo;
  PDF(new window)
The aims of this study were to investigated the occurrence of caffeine and carbamazepine in Nakdong river basin (8 mainstreams and 2 tributaries) and the behavior of caffeine and carbamazepine under drinking water treatment processes (conventional and advanced processes). The examination results showed that caffeine was detected at all sampling sites (5.4~558.5 ng/L), but carbamazepine was detected at five sampling sites (5.1~79.4 ng/L). The highest concentration level of caffeine and carbamazepine in the mainstream and tributaries in Nakdong river were Goryeong and Jinchun-cheon, respectively. These pharmaceutical products were completely removed when they were subject to conventional plus advanced processes of drinking water treatment processes. Conventional processes of coagulation, sedimentation and sand-filtration were not effective for their removal, while advanced processes of ozonation and biological activated carbon (BAC) filtration were effective. Among these pharmaceuticals, carbamazeoine was more subject to ozonation than caffeine.
Residual Pharmaceuticals;Caffeine;Carbamazepine;Drinking Water Treatment Process;Behavior;
 Cited by
서창동, 손희종, 이인석, 오정은, 2010, 낙동강 수계에서의 인공 사향물질 검출 특성, 대한환경공학회지, 32(6), 615-624.

손희종, 장성호, 2006, 상수원에서의 잔류 의약물질 검출, 거동, 분포현황 및 독성, 대한환경공학회지, 33(6), 453-479.

Barone, J. J., Roberts, H., 1999, Caffeine consumption, Food and Chemical Toxicology, 34, 119-129 (1996). crossref(new window)

Choi, K., Kim, Y., Park, J., Park, C., Kim, M., Kim, H., Kim, P., 2008, Seasonal variations of several pharmaceutical residues in surface water and sewage treatment plants of Han River, Korea, Sci. of Total Environ., 405(1-3), 120-128. crossref(new window)

Dorne, J. L. C., Ragas, A. M., Frampton, G. K., Spurgeon, D. S., Lewis, D. F., 2007, Trends in human risk assessment of pharmaceuticals, Anal. Bioanal. Chem., 387, 1167-1172. crossref(new window)

Esplugas, S., Bila, D. M., Krause, L. G. T., Dezotti, M., 2007, Ozonation and advanced oxidation technologies to remove endocrine disrupting chemicals (EDCs) and pharmaceuticals and personal care products (PPCPs) in water effluents," J. Hazard. Mater., 149, 631-642. crossref(new window)

Fent, K., Weston, A. A., Caminada, D., 2006, Ecotoxicology of human pharmaceuticals, Aquqt. Toxicol., 76, 122-159. crossref(new window)

Halling-Sorensen, B., Nors Nielsen, S., Lanzky, P. F., Ingerslev, F., Holten Lützhøft, H. C., Jørgensen, S. E., 1998, Occurrence, fate and effects of pharmaceutical substances in the environment-a review, Chemosphere, 36, 357-393. crossref(new window)

Kim, P. G., Kim, M. Y., Choi, K. H., 2005, Pharmaceutical residues in Han River and their impact on freshwater ecosystem, Report, Korea Research Foundation.

Kim, S. D., Cho, J., Kim, I. S., Vanderford, B. J., Snyder, S. A., 2007, Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste water, Water Res., 41(5), 1013-1021. crossref(new window)

Kolpin, D. W., Furlong, E. T., Meyer, M. T., Thurman, E. M., Zaugg, S. D., Barber, L. R., Buxton, H. T., 2002, Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance, Environ. Sci. Technol., 36, 1202-1211. crossref(new window)

Kuster, M., Alda, M. J. L., Hernando, M. D., Petrovic, M., Martin-Alonso, J., Barcelo, D., 2008, Analysis an occurrence of pharmaceuticals, estrogens, progestogens and polar pesticides in sewage treatment plant effluents, river water and drinking water in the Llobregat river basin (Barcelona, Spain), J. Hydrol., 358, 112-123. crossref(new window)

Lee, O. C., Howe, J. K., Thomson, M. B., 2005, Ozone and biofiltration as an alternative to reverse osmosis for removing PPCPs and micropollutants from treated wastewater, Water Res., 46, 1005-1014.

McDowell, D. C., Huber, M. M., Wagner, M., von Gunten, U., Ternes, T. A., 2005, Ozonation of carbamazepine in drinking water: identification and kinetic study of major oxidation products, Environ. Sci. Technol., 39(20), 8014-8022. crossref(new window)

Reungoat, J., Escher, B. I., Macova, M.,Keller, J., 2011, Biofiltration of wastewater treatment plant effluent: effective removal of pharmaceuticals and personal care products and reduction of toxicity, Water Res., 45, 2751-2762. crossref(new window)

Santos, L. H. M. L. M., Araújo, A. N., Fachini, A., Pena, A., Delerue-Matos, C., Montenegro, M. C. B. S. M., 2010, Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment, J. Hazard. Mater., 175, 45-95. crossref(new window)

Seiler, R. L., Zaugg, S. D., Thomas, J. M., Howcroft, D. L., "Caffeine and pharmaceuticals as indicators of waste water contamination in wells, Ground Water, 37, 405-410.

Siegener, R., Chen, R. F., 2002, Caffeine in Boston Harbour seawater, Mar. Pollut. Bull., 44, 383-387. crossref(new window)

Snyder, S. A., 2008, Occurrence, treatment and toxicological relevance of EDCs and pharmaceuticals in water, Ozone Sci. Eng., 30, 65-69. crossref(new window)

Thacker, P. D., 2005, Pharmaceutical data elude researchers, Environ. Sci. Technol., 39, 193A-194A.

Westerhoff, P., Yoon, Y., Snyder, S., Wert, E., 2005, Fate of endocrine-disruptor, pharmaceutical, and personal care product chemicals during simulated drinking water treatment processes, Environ. Sci. Technol., 39, 6649-6663. crossref(new window)

Yang, S. H., Carlson, K., 2002, Evolution of antibiotic occurrence in a river through pristine, urban and agricultural landscapes, Water Res., 37, 4645-4656.